Sneha Anand
Postdoctoral Researcher
I completed my MSc in medical biotechnology from AIIMS, New delhi, India during which I studied the host-pathogen interaction in infections caused by Mycobacterium. I obtained my PhD in 2016 from Jawaharlal Nehru University, New Delhi India. My PhD mainly focussed on understanding the immunobiology of a parasitic disease called leishmaniasis with an aim to develop novel therapeutics against the parasite. Before joining Prof. Rabbitts group I was working as a postdoc in Dr Matthew Reeves and Prof Greg Towers group at University college London. Here I was interested in identifying and characterizing the antiviral activity of novel small molecule inhibitors targeting the host protein Cyclophillin-A. I joined Prof Rabbitts group in October 2017 and my work here will focus on utilizing and developing methodologies to target protein-protein interactions using antibody fragments.
Recent publications
-
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study.
Journal article
Meeraus W. et al, (2024), J Infect, 88
-
Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales.
Journal article
Bedston S. et al, (2024), Lancet Reg Health Eur, 37